Companies ›Industrials ›RECT.BR

RECT.BR — Euronext Brussels Diversified Industrial Machinery

Recticel SA

€12,42

Open in Charts → Attach watcher ⌖

— —

EUR

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

3,07 %

Op margin

1,3 %

ROE

2,4 %

Net margin

1,6 %

Debt / equity

0,13

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

2026-10-28

Ex-dividend

—

TR 1Y

—

About

Recticel SA is a chemicals company that produces commodity chemicals and operates in the basic materials sector, primarily generating revenue through the manufacturing and sale of chemical products.

Business. Recticel SA (RECT.BR) is a Belgian company operating in the commodity chemicals industry within the broader chemicals sector. The firm is headquartered in Belgium and is primarily listed on the Euronext Brussels exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification99 %

SectorIndustrials

Industry groupDiversified Industrial Machinery

Generated · model-assisted

Sell-side consensus

BUY6 analysts

4 buy2 hold0 sell

Avg 12m price target12,60

Analyst recommendations

6 analysts · consensus Buy

Buy4

Hold2

Sell0

12-month price target

12,60

Consensus of sell-side coverage.

Upcoming events

EarningsQ2 2026 earnings (expected)2026-10-28 · estimated

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts→

Buy

6 analysts · indicative

Ownership

—

not yet wired

Profitability→

2,4 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning RECT.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials · THIS SECTOR−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to RECT.BR. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Company
EarningsQ2 2026 earnings (expected)2026-10-28 · estimated
Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

Recticel SA (RECT.BR) is a Belgian company operating in the commodity chemicals industry within the broader chemicals sector. The firm is headquartered in Belgium and is primarily listed on the Euronext Brussels exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification99 %

SectorIndustrials

Industry groupDiversified Industrial Machinery

AI synthesis

GENERATED

Recticel maintains a strong liquidity position, with a current ratio of 1.83 and cash and equivalents amounting to EUR 82.25 million, which supports its short-term obligations. The company's debt-to-equity ratio is 0.13, indicating a conservative capital structure with limited leverage.

Profitability metrics show that Recticel's return on equity is 2.39%, and its return on assets is 1.49%, both of which are below the industry median for commodity chemicals. The company's operating income of EUR 8.39 million and net income of EUR 10.20 million reflect modest profitability relative to its asset base.

Recticel's revenue is concentrated in the chemicals segment, with no disclosed geographic diversification in the provided data. The company's exposure to a single business line may increase its vulnerability to sector-specific downturns.

The company's growth trajectory is mixed, with a free cash flow of EUR -14.87 million and capital expenditures of EUR -34.28 million in the latest period. While revenue remains stable at EUR 655.08 million, the negative free cash flow suggests reinvestment in operations rather than distribution to shareholders.

Risk factors for Recticel include low liquidity risk and low dilution risk, with no immediate filing-based flags detected. The company's low leverage and strong cash position reduce financial risk, but its modest profitability and reinvestment needs may limit long-term returns.

Recent events include analyst price targets ranging from EUR 10.90 to EUR 14.70, with a mean recommendation of 2.17, indicating a generally positive outlook from the investment community.

Key takeaways

Recticel maintains a conservative capital structure with a low debt-to-equity ratio of 0.13 and strong liquidity.
The company's profitability is modest, with ROE and ROA below industry medians for commodity chemicals.
Revenue is concentrated in a single business segment, with no disclosed geographic diversification.
Free cash flow is negative, indicating reinvestment in operations rather than shareholder returns.
Analysts have a generally positive outlook, with a mean price target of EUR 12.60 and a recommendation of 2.17.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation

Market price

€12,42

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

€427.1M

Net cashⓘ

€27.7M

Current ratioⓘ

1.8

Debt / equityⓘ

0.1

ROAⓘ

1.5%

ROEⓘ

2.4%

Cash conversionⓘ

358.0%

CapEx / revenueⓘ

-5.2%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Personal Protective Equipment70,0 %

low · business_description · 2026-07-04

Fall Protection Systems—

low · business_description · 2026-07-04

Fire Protection Equipment—

low · business_description · 2026-07-04

Power Tools & Outdoor Equipment—

low · business_description · 2026-07-04

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

Peer comparison8 peers · vs RECT · multiples and returns

PH—

Parker Hannifin Corp

$978,08

127,3B USD

P/E

35,4x

+26,5 vs self

Div yield

0,7 %

— vs self

ROE

25,8 %

+16,8 vs self

GWW—

Ww Grainger Inc

$1 367,46

64,8B USD

P/E

38,0x

+29,1 vs self

Div yield

0,6 %

— vs self

ROE

43,4 %

+34,4 vs self

SWK—

STANLEY BLACK & DECKER, INC.

$98,11

14,9B USD

P/E

34,4x

+25,5 vs self

Div yield

3,6 %

— vs self

ROE

4,5 %

-4,5 vs self

XYL—

Xylem Inc

$119,08

28,6B USD

P/E

28,5x

+19,7 vs self

Div yield

1,4 %

— vs self

ROE

9,2 %

+0,1 vs self

FAST—

Fastenal Co

$48,11

55,4B USD

P/E

42,7x

+33,8 vs self

Div yield

1,9 %

— vs self

ROE

31,5 %

+22,5 vs self

DOV—

Dover Corp

$205,72

27,9B USD

P/E

28,2x

+19,3 vs self

Div yield

1,0 %

— vs self

ROE

14,2 %

+5,2 vs self

IR—

Ingersoll-rand Inc

$81,77

32,2B USD

P/E

55,4x

+46,5 vs self

Div yield

—

— vs self

ROE

5,7 %

-3,3 vs self

CNM—

Core & Main Inc

$45,75

9,0B USD

P/E

21,2x

+12,4 vs self

Div yield

—

— vs self

ROE

21,6 %

+12,6 vs self

Market position

Stress test

— missing data

Predictor forecast

Next quarternear-term

Earnings · next quarterconf 45 %

EPS

Consensus EPS

0,42

Predicted surprise

+0,00

Beat probability

45 %

Analysts

Other metrics

Revenue

—

no estimate

Segment revenue

—

no estimate

Margin

—

no estimate

Segment margin

—

no estimate

as of 2026-05-23 · Earnings Surprise V1

Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.

Full fiscal year~1 year ahead

Full fiscal year · our forecast vs guidance vs consensus

Metric	Our forecast	Guidance	Consensus
EPS	—no estimate	—no estimate	0,42
Revenue	—no estimate	—no estimate	719,0M EUR
Operating income	—no estimate	—no estimate	32,9M EUR

Full-year consensus mean (period as reported by source) · consensus in EUR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.

Probabilistic model output — not investment advice. · generated 2026-08-04

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Consensus distribution

sell-side coverage

Recommendation distribution6 analysts

Strong buy1

Buy3

Hold2

Sell0

Strong sell0

12-month price target€12,60 · Median €12,25

Low €10,90High €14,70

Operating income · consensus32,9M EUR

EPS surprise

−37,5 %

reported vs consensus · miss

Revenue surprise

−8,9 %

reported vs consensus · miss

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

Low€10,90

Mean€12,60

Median€12,25

High€14,70

Spot€12,42

+1.4 %implied to mean12-month sell-side price targets · ▲ spot

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskLow

Filing-based flags

No immediate filing-based liquidity or dilution flags were detected.

Benchmarks vs cohort

Op Margin1,3 %Bottom quartile

Net Margin1,6 %Below median

ROE2,4 %Below median

Capex / Rev-5,2 %Bottom quartile

D/E0,13Above median

Cash Conv3,58Best in class

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

Recticel SA Market data — financials · 2026-05-29
Recticel SA Market data — analyst estimates · 2026-05-29
Recticel SA Market data — ESG · 2026-05-29

Ownership & reference

Insider activity

— missing data

Short positioning

9.6Kshares short-9.2% vs prior

1.64days to cover

78.0%short of daily vol

39fails-to-deliver

as of 2026-07-15 · short-interest report (free)

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

RECT.BRCanonical

Euronext Brussels · EUR

Intel & risk

PredictorBeat prob45 %Surprise+0,00Full forecast →

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskLow

No immediate filing-based liquidity or dilution flags were detected.

Evidence & claims

From filings & derived data

Operating income (annual): USD 3.31MUnknown
Pre-tax income (annual): USD 3.68MUnknown
Gross profit (annual): USD 12.78MUnknown
Total operating expenses (annual): USD 9.48MUnknown
EPS (basic) (annual): USD-PER-SHARES 0Unknown
Operating cash flow (annual): USD -1.67MUnknown
EPS (diluted) (annual): USD-PER-SHARES 0Unknown
Cost of revenue (annual): USD 26.96MUnknown
Revenue (annual): USD 39.74MUnknown
Net income (annual): USD 2.78MUnknown
Capex (annual): USD 153.02KUnknown
Cost of revenue (YoY) (2025-03-31 vs 2024-03-31): 9.3%Derived (calculated)
Gross margin (FY 2025-03-31): 33.7%Derived (calculated)
Revenue (YoY) (2025-03-31 vs 2024-03-31): 6.1%Derived (calculated)
Operating cash flow (YoY) (2025-03-31 vs 2024-03-31): -95.2%Derived (calculated)
R&D expense (YoY) (2025-03-31 vs 2024-03-31): 105.9%Derived (calculated)
Operating income (YoY) (2025-03-31 vs 2024-03-31): -46.1%Derived (calculated)
Gross profit (YoY) (2025-03-31 vs 2024-03-31): 0.4%Derived (calculated)
EPS (basic) (YoY) (2025-03-31 vs 2024-03-31): -40.0%Derived (calculated)
Net income (YoY) (2025-03-31 vs 2024-03-31): -33.2%Derived (calculated)
Capex (YoY) (2025-03-31 vs 2024-03-31): 162.2%Derived (calculated)
Net margin (FY 2025-03-31): 5.1%Derived (calculated)
EPS (diluted) (YoY) (2025-03-31 vs 2024-03-31): -40.0%Derived (calculated)
Revenue (annual): USD 32.57MSEC XBRL filing

Showing 24 of 45 surfaced claims.

Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

The Thread

Everything we know, in order

2026-10-28EVENTUpcomingQ2 2026 earnings (expected) estimated date

2026-06-30 06:00 UTCEARNINGSUpcomingForecast: price_forecast (5d)

2026-06-30 06:00 UTCEARNINGSUpcomingForecast: price_forecast (1d)

2026-06-30 06:00 UTCEARNINGSUpcomingForecast: price_forecast (90d)

2026-06-30 06:00 UTCEARNINGSUpcomingForecast: price_forecast (30d)

2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)

2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated

2026-03-20FILINGREPORT OF FOREIGN PRIVATE ISSUER →

2026-03-10FILINGREPORT OF FOREIGN PRIVATE ISSUER →

2025-10-27FILINGREPORT OF FOREIGN PRIVATE ISSUER →

2025-10-03FILINGREPORT OF FOREIGN PRIVATE ISSUER →

2025-09-08FILINGREPORT OF FOREIGN PRIVATE ISSUER →

2025-09-02FILINGREPORT OF FOREIGN PRIVATE ISSUER →

2025-08-21FILINGREPORT OF FOREIGN PRIVATE ISSUER →

2025-07-31FILINGANNUAL REPORT →

2025-07-31FILINGREPORT OF FOREIGN PRIVATE ISSUER →

2025-03-27FILINGREPORT OF FOREIGN PRIVATE ISSUER →

2025-02-19FILINGREPORT OF FOREIGN PRIVATE ISSUER →

2025-01-22FILINGFORM 6-K →

The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

Analyst recommendations

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Consensus distribution

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread